IRIS Institutional Research Information System - OPENBS Open Archive UniBS

Laganà, Marta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 697
EU - Europa 496
AS - Asia 119
AF - Africa 3
OC - Oceania 1
SA - Sud America 1
Totale 1.317
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 690
PL - Polonia 220
IT - Italia 63
FI - Finlandia 53
DE - Germania 49
CN - Cina 48
UA - Ucraina 41
HK - Hong Kong 36
VN - Vietnam 24
IE - Irlanda 21
GB - Regno Unito 18
SE - Svezia 15
CA - Canada 7
IN - India 7
BE - Belgio 6
FR - Francia 6
RU - Federazione Russa 3
SG - Singapore 2
ZW - Zimbabwe 2
AU - Australia 1
AZ - Azerbaigian 1
CL - Cile 1
IR - Iran 1
MU - Mauritius 1
NL - Olanda 1
Totale 1.317
Salva come PNG Salva come JPEG
Città #
Warsaw 220
Fairfield 112
Ashburn 70
Chandler 66
Helsinki 51
Seattle 45
Wilmington 43
Woodbridge 43
Cambridge 37
Hong Kong 36
Princeton 35
Houston 34
Jacksonville 34
New York 34
Dong Ket 24
Dublin 19
Beijing 18
Brescia 12
West Jordan 12
Ann Arbor 10
London 7
Naples 7
Shanghai 7
Brussels 6
Dalmine 6
Dearborn 6
Des Moines 6
Livorno 6
Los Angeles 6
Pune 6
San Diego 5
Turin 5
Chicago 4
Jinan 4
Toronto 4
Changsha 3
Redwood City 3
Shenyang 3
Berlin 2
Brooklyn 2
Gunzenhausen 2
Lappeenranta 2
Leawood 2
Leipzig 2
Milan 2
Nanjing 2
Ningbo 2
Phoenix 2
San Francisco 2
Taizhou 2
Washington 2
Würzburg 2
Acton 1
Amsterdam 1
Ardabil 1
Augusta 1
Borås 1
Caserta 1
Cinisello Balsamo 1
Dallas 1
Falkenstein 1
Fuzhou 1
Guangzhou 1
Hebei 1
Hounslow 1
Huzhou 1
Islington 1
Kunming 1
Mantova 1
Melbourne 1
Mumbai 1
Napoli 1
North York 1
Norwalk 1
Pignone 1
Québec 1
Redmond 1
Rome 1
Santiago 1
Tianjin 1
Wuxi 1
Totale 1.106
Salva come PNG Salva come JPEG
Nome #
Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures 159
Immunotherapy failure in adrenocortical cancer: where next? 153
Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells 121
Antineoplastic Activity of Artemisinin in Adrenocortical Carcinoma 96
Adrenocortical Carcinoma and CT Assessment of Therapy Response: The Value of Combining Multiple Criteria 95
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 92
Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients with Advanced Adrenocortical Carcinoma: The Brescia Experience. 86
Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: A multicenter retrospective study 77
Treatment with 90Y/177Lu DOTATOC in patients with metastatic adrenocortical carcinoma expressing somatostatin receptors 72
High Prevalence and Early Occurrence of Skeletal Complications in EGFR Mutated NSCLC Patients With Bone Metastases 60
Hyperthermic Intraperitoneal Chemotherapy for Primary or Recurrent Adrenocortical Carcinoma. A Single Center Study. 53
The long and winding road to effective immunotherapy in patients with adrenocortical carcinoma 46
Ribociclib Cytotoxicity Alone Or Combined With Progesterone And/Or Mitotane In In Vitro Adrenocortical Carcinoma Cells 43
Letter to the editor from Berruti et al: "Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients' Survival" 36
Estrogen-Like Effect of Mitotane Explained by Its Agonist Activity on Estrogen Receptor-α 32
Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art? 30
S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study 27
Progression of vertebral fractures in patients with adrenocortical carcinoma undergoing mitotane therapy 27
Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen 26
Role of Body Composition in the Prediction of Skeletal Fragility Induced by Hormone Deprivation Therapies in Cancer Patients 8
Prediction of fragility fractures in men with prostate cancer under androgen deprivation therapy: the importance of a multidisciplinary approach using a mini-invasive diagnostic tool 6
null 5
Letter re: Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma: A population-based study 1
Totale 1.351
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.501
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.501
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201921 0 0 0 0 0 0 0 0 0 0 11 10
2019/2020266 9 6 6 11 18 31 25 31 28 35 29 37
2020/2021464 22 32 45 57 35 63 20 47 30 49 26 38
2021/2022177 18 10 6 10 8 8 13 10 8 30 19 37
2022/2023172 24 12 13 12 14 36 2 21 17 0 13 8
2023/2024251 14 8 27 35 23 56 6 16 47 18 1 0
Totale 1.351